SCHEMBL14923733

SCHEMBL14923733

NCCNc1nc(Nc2cccc(Cl)c2)c(C(N)=O)cc1F

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 16/20 0.52
ZAP70 P43403 5/20 0.52
KCNH2 Q12809 1/20 0.52
AURKB Q96GD4 1/20 0.52
CAMK1D Q8IU85 2/20 0.52
PRKCE Q02156 1/20 0.51
BTK Q06187 1/20 0.51
ITK Q08881 1/20 0.51
PIM1 P11309 2/20 0.46
JAK2 O60674 1/20 0.46
ROCK2 O75116 1/20 0.46
MAP4K4 O95819 1/20 0.46
HCK P08631 1/20 0.46
ROS1 P08922 1/20 0.46
PRKACA P17612 1/20 0.46
MARK3 P27448 1/20 0.46
LTK P29376 1/20 0.46
FLT3 P36888 1/20 0.46
CSNK1A1 P48729 1/20 0.46
CLK2 P49760 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14909406 0.89 SYK (0.49) SYKZAP70KCNH2AURKBCAMK1D
SCHEMBL14923798 0.88 SYK (0.53) SYKZAP70KCNH2AURKBCAMK1D
SCHEMBL14908623 0.88 AURKA (0.51) SYKZAP70KCNH2AURKBCAMK1D
SCHEMBL14923870 0.87 SYK (0.69) SYKZAP70KCNH2AURKBCAMK1D
SCHEMBL14910698 0.86 SYK (0.54) SYKZAP70KCNH2AURKBCAMK1D
SCHEMBL14910187 0.86 SYK (0.57) SYKZAP70KCNH2AURKBCAMK1D
SCHEMBL14909036 0.85 SYK (0.46) SYKZAP70KCNH2AURKBCAMK1D
SCHEMBL14923748 0.85 SYK (0.53) SYKZAP70KCNH2AURKBCAMK1D
SCHEMBL14923850 0.85 SYK (0.71) SYKZAP70KCNH2AURKBCAMK1D
SCHEMBL14911348 0.85 SYK (0.53) SYKZAP70KCNH2AURKBCAMK1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2589592-B1 NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF FUJIFILM CORP (JP) 2018-08-22 EP disclosed
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 US disclosed
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 US disclosed
US-8809371-B2 2014-08-19 US disclosed
US-8809371-B2 2014-08-19 US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 US disclosed
EP-2589592-A1 NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF FUJIFILM Corporation (JP) 2013-05-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, CD38, BTK SYK 1/4885ZAP70 183/4885KCNH2 1263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.